Inhibitory activity of IAA and IBA against lipoxygenase: in silico and in vitro validation

REFERENCES

• RobersoED, MuckeL. 100 years and counting: prospects for defeating Alzheimer's disease. Science. 2006;314:781–784.
   PubMed Web of Science ®Google Scholar
• MelnikovaI. Therapies for Alzheimer's disease. Nat Rev Drug Discovery. 2007;6:341–342.
   PubMed Web of Science ®Google Scholar
• LammersCH, SchweitzerP, FacchinettiP, ArrangJM, MadambaSG, SigginsGR, PiomelliD. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J Neurochem. 1996;66:147–152.
   PubMed Web of Science ®Google Scholar
• ManevH, UzT, SugayaK, QuT. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 2000;14:1464–1469.
   PubMed Web of Science ®Google Scholar
• TomimotoH, ShibataM, IharaM, AkiguchiI, OhtaniR, BudkaH. A comparative study on the expression of cyclooxygenase and 5-lipoxygenase during cerebral ischemia in humans. Acta Neuropathol (Berl). 2002;104:601–607.
   PubMed Web of Science ®Google Scholar
• ZhangL, ZhangWP, HuH, WangML, ShengWW, YaoHT, DingW. Expression patterns of 5-lipoxygenase in human brain with traumatic injury and astrocytoma. Neuropathology. 2006;26:99–106.
   PubMed Web of Science ®Google Scholar
• ZhouY, WeiEQ, FangSH, ChuLS, WangML, ZhangWP, YuGL. Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats. Life Sci. 2006;79:1645–1656.
   PubMed Web of Science ®Google Scholar
• ChinniciCM, YaoY, PraticòD. The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old. Neurobiol Aging. 2007;28:1457–1462.
   PubMed Web of Science ®Google Scholar
• FiruziO, ZhuoJ, ChinniciCM, WisniewskiT, PraticòD. 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease. FASEB J. 2008;22:1169–1178.
   PubMed Web of Science ®Google Scholar
• GoodmanY, SteinerMR, SteinerSM, MattsonMP. Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β-peptide toxicity, and attenuates free radical and calcium accumulation. Brain Res. 1994;654:171–176.
   PubMed Web of Science ®Google Scholar
• SugayaK, UzT, KumarV, ManevH. New anti-inflammatory treatment strategy in Alzheimer's disease. Jpn J Pharmacol. 2000;82:85–94.
   PubMedGoogle Scholar
• KlegerisA, McGeerPL. Cyclooxygenase and 5-lipoxygenase inhibitors protect against mononuclear phagocyte neurotoxicity. Neurobiol Aging. 2002;23:787–794.
   PubMed Web of Science ®Google Scholar
• HutchinsonJH, CharlesonS, EvansJF, FalgueyretJP, HoogsteenK, JonesTR, KargmanS, MacdonaldD, McFarlaneCS, NicholsonDW. Thiopyranol [2,3,4-c,d] indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase. J Med Chem. 1995;38:4538–4547.
   PubMed Web of Science ®Google Scholar
• CharlierC, MichauxC. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) as a new strategy to provide safer nonsteroidal anti-inflammatory drugs. Eur J Med Chem. 2003;38:645–659.
   PubMed Web of Science ®Google Scholar
• DillardRD, BachNJ, DraheimSE, BerryDR, CarlsonDG, ChirgadzeNY, ClawsonDK, HartleyLW, JohnsonLM, JonesND, McKinneyER, MihelichED, OlkowskiJL, SchevitzRW, SmithAC, SnyderDW, SommersCD, WeryJP. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-acetamides. J Med Chem. 1996;39:5119–5136.
   PubMed Web of Science ®Google Scholar
• DraheimSE, BachNJ, DillardRD, BerryDR, CarlsonDG, ChirgadzeNY, ClawsonDK, HartleyLW, JohnsonLM, JonesND, McKinneyER, MihelichED, OlkowskiJL, SchevitzRW, SmithAC, SnyderEW, SommersCD, WeryJP. Indole inhibitors of human nonpancreatic secretory phospholipase A2. 3. Indole-3-glyoxamides. J Med Chem. 1996;39:5159–5175.
   PubMed Web of Science ®Google Scholar
• HagishitaS, YamadaM, ShirahaseK, OkadaT, MurakamiY, ItoY, MatsuuraT, WadaM, KatoT, UenoM, ChikazawaY, YamadaK, OnoT, TeshirogiI, OhtaniM. Potent inhibitors of secretory phospholipase A2: synthesis and inhibitory activities of indolizine and indene derivatives. J Med Chem. 1996;39:3636–3658.
   PubMed Web of Science ®Google Scholar
• YokotaY, HanasakiK, OnoT, NakazatoH, KobayashiT, AritaH. Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms. Biochim Biophys Acta. 1999;1438:213–222.
   PubMed Web of Science ®Google Scholar
• MouchlisVD, MavromoustakosTM, KokotosGJ. Molecular docking and 3D-QSAR COMFA studies on indole inhibitors of GIIA secreted phospholipase A2. Chem Inf Model. 2010;50:1589–1601.
   PubMed Web of Science ®Google Scholar
• AnyanfulA, Dolan-LivengoodJM, LewisT, ShethS, DezaliaMN, ShermanMA, KalmanLV, BenianGM, KalmanD. Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene. Mol Microbiol. 2005;57:988–1007.
   PubMed Web of Science ®Google Scholar
• HirakawaH, KodamaT, Takumi-KobayashiA, HondaT, YamaguchiA. Secreted indole serves as a signal for expression of type III secretion system translocators in enterohaemorrhagic Escherichia coli. Microbiology. 2009;155:541–550.
   PubMed Web of Science ®Google Scholar
• LeeJ, AttilaC, CirilloSLG, CirilloJD, WoodTK. Indole and 7-hydroxyindole diminish Pseudomonas aeruginosa virulence. Microb Biotech. 2009;2:75–90.
   PubMed Web of Science ®Google Scholar
• LeeJ, JayaramanA, WoodTK. Indole is an inter-species biofilm signal mediated by SdiA. BMC Microbiol. 2007;7:42.
   PubMed Web of Science ®Google Scholar
• Di MartinoP, FursyR, BretL, SundararajuB, PhillipsRS. Indole can act as an extracellular signal to regulate biofilm formation of Escherichia coli and other indole-producing bacteria. Can J Microbiol. 2003;49:443–449.
   PubMed Web of Science ®Google Scholar
• PalKK, TilakKV, SaxenaAK, DeyR, SinghC. Suppression of maize root diseases caused by Macrophomina phaseolina, Fusarium moniliforme and Fusarium graminearum by plant growth promoting rhizobacteria. Microbiol Res. 2001;156:209–223.
   PubMed Web of Science ®Google Scholar
• FolkesLK, GrecoO, DachsGU, StratfordMR, WardmanP. 5-Fluoroindole-3-acetic acid: a prod rug activated by a peroxidase with potential for use in targeted cancer therapy. Biochem Pharmacol. 2002;63:265–272.
   PubMed Web of Science ®Google Scholar
• DileepKV, RemyaC, TintuI, HaridasM, SadasivanC. Interactions of selected indole derivatives with phospholipase A2: in silico and in vitro analysis. J Mol Model. 10.1007/s00894-012-1741-4.
   Web of Science ®Google Scholar
• DileepKV, TintuI, RemyaC, HaridasM, SadasivanC. Studies of IAA and IBA as fungal α-amylase inhibitors using enzyme kinetics, molecular modeling and thermodynamics. Starch/Stärke. 2012;64:991–995.
   Web of Science ®Google Scholar
• BorbulevychOY, JankunJ, SelmanSH, Skrzypczak-JankunE. Lipoxygenase interactions with natural flavonoid, quercetin, reveal a complex with protocatechuic acid in its X-ray structure at 2.1 Å resolution. Proteins Struct Funct Genet. 2004;54:13–19.
   PubMed Web of Science ®Google Scholar
• HalgrenTA. Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J Comput Chem. 1996;17:490–519.
   Web of Science ®Google Scholar
• ChengY, PrussoffWH. Relationship between the inhibition constant and the concentration of inhibitor which causes 50% inhibition of an enzymatic reaction. Biochem Pharmacol. 1973;22:3099–3108.
   PubMed Web of Science ®Google Scholar
• Skrzypczak-JankunE, BorbulevychOY, JankunJ. Soybean lipoxygenase-3 in complex with 4-nitrocatechol. Acta Crystallogr D Biol Crystallogr. 2004;60:613–615.
   PubMed Web of Science ®Google Scholar